Jun 2, 2020 · Over 100 studies are under way to find a vaccine for COVID-19. Vaccination is one of the world’s most successful health interventions, saving as many as 3 million lives every year. But a further 1.5 million deaths a year could be avoided with improved global coverage. Cost, conflict and vaccine hesitancy are among the barriers.

Aug 25, 2020 · One of these plans, COVAX, is a scheme created to provide fast, equitable access to a COVID-19 vaccine around the world. COVAX is trying to raise sufficient funds to make 2 billion doses of effective vaccine available by late 2021.

Jan 31, 2022 · The large crowds gathered to protest COVID-19 vaccine mandates suggest hesitancy may be more common in Europe than survey results indicate, according to this piece – which traces some of the region’s anti-vaccination history. (Institut Montaigne)

Jun 8, 2021 · The world will need billions of COVID-19 vaccine doses. Around the world, there is a concerted effort under way to vaccinate as many people as possible against COVID-19, as quickly as possible. After slow starts in some countries, steady progress is now being made - although the rollout remains unequal .

Aug 3, 2021 · “Vaccine inequity is the world’s biggest obstacle to ending this pandemic and recovering from COVID-19,” Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), said last month.

Aug 15, 2024 · Shyam Bishen explains, "The availability of a vaccine is encouraging news in the fight against mpox, but as with COVID-19, equitable distribution and access to vaccines will be a key challenge globally due to uneven rollouts and uptake rates between high-income and low-and-middle-income countries.

Jul 14, 2020 · The COVID-19 coronavirus crisis has wrought economic disruption on a monumental scale, contributing to a dangerous and volatile global upheaval – politically, socially and geopolitically – while raising deep concerns about the environment and the extending reach of technology into our lives.

Dec 8, 2021 · Uneven vaccine rollout saw African nations receive just 2% of the 5.7 billion doses administered around the world, the WHO announced. Johnson & Johnson released results of a real-world study showing a 74% efficacy rating for its COVID-19 vaccine.

Jan 6, 2021 · The richest nations have secured billions of doses of COVID-19 vaccines, while developing economies struggle to access supplies. Vaccine nationalism – where countries push to get first access – could slow the global economic recovery, costing high …

Feb 17, 2022 · COVID-19 caused a surge in demand for personal protective equipment (PPE), much of which is made of plastic. Eight billion vaccine doses have generated an additional 144,000 tonnes of waste. The World Health Organization is calling for reforms surrounding the disposal of medical waste.